This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
” “Our goal,” it stated, “must be to develop the talents of all to their fullest.” The talents of all are not being developed to their fullest, and many U.S. million job openings , which companies are struggling to find the right talent to fill. industries face acute skills shortages.
Most leaders struggle to find and develop the ready-now talent they need. But should leaders even bother spending time trying to develop employees and plan for the future, given the turbulence in the labor market and uncertainty in the world? Development investments do not always deliver on promised results.
In addition, BCG hosts combined Training & Development events between the San Francisco and Palo Alto offices to incorporate team-building across offices and engage them in learning together. The San Francisco office has also developed a strong learning culture. The firm was ranked No. Deloitte Consulting , 101 Market St.,
Innovation ranks fifth, after more-conventional concerns such as attracting and retaining top talent and the regulatory environment. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., food, beverage & tobacco, household and personal products); Energy & Utilities (e.g.,
The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.
These policy differences fostered the emergence of a less loyal, more footloose talent pool in Silicon Valley. In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices.
The management development program results were: 92.5% Net Promoter Score This global biotechnology company is experiencing 15% year-over-year growth and needed new and inexperienced people managers to be able to better lead, manage, and coach their teams through growth and change. Job Relevance 98.2% Learn more about getting aligned.
About LSA Global Founded in 1995, LSA Global is the leading performance consulting, coaching, and training firm that helps high growth technology, services, and life-science companies create a competitive advantage by powerfully aligning their culture and talent with their strategy. Learn more about getting aligned.
Directors are also consistent in their views of the key challenges to achieving their companies’ strategic objectives: attracting and retaining top talent, the regulatory environment, and domestic competitive threats top the list for directors from both parties. banking & financial services, insurance, real estate); Healthcare (e.g.,
As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. On the one hand, streamlining regulations and reducing bureaucratic hurdles could accelerate the development and approval of new therapies.
We organize all of the trending information in your field so you don't have to. Join 55,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content